Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Patrignani

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1985
Drugs, prostaglandins, and renal functionC Patrono, G Ciabattoni, P Filabozzi, et al.
European Heart Journal|May 1, 1985
Low-dose aspirin in patients recovering from myocardial infarction. Evidence for a selective inhibition of thromboxane-related platelet functionR De Caterina, D Giannessi, W Bernini, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1994
Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthasesP Patrignani, M R Panara, A Greco, et al.
International Journal of Immunopathology and Pharmacology|June 13, 2013
Clinical pharmacology of cyclooxygenase inhibition and pharmacodynamic interaction with aspirin by floctafenine in Thai healthy subjectsR Maenthaisong, S Tacconelli, P Sritara, et al.
Anesthesia and Analgesia|January 1, 1985
Dose-related prolongation of the bleeding time by intravenous nitroglycerinP R Lichtenthal, E C Rossi, G Louis, et al.
Apoptosis : an International Journal on Programmed Cell Death|November 25, 2003
Cyclooxygenase-independent induction of p21WAF-1/cip1, apoptosis and differentiation by L-745,337, a selective PGH synthase-2 inhibitor, and salicylate in HT-29 cellsG Santini, M G Sciulli, R Marinacci, et al.
La Clinica Terapeutica|February 11, 2005
[Rationale of the use of COX-2 inhibitors in ENT pathologies]D Passali, M De Benedetto, C Giordano, et al.
The Journal of Clinical Investigation|January 1, 1982
Evidence for a direct stimulatory effect of prostacyclin on renin release in manC Patrono, F Pugliese, G Ciabattoni, et al.
British Journal of Pharmacology|July 1, 1996
Induction of prostaglandin endoperoxide synthase-2 in human monocytes associated with cyclo-oxygenase-dependent F2-isoprostane formationP Patrignani, G Santini, M R Panara, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 25, 1999
Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjectsM R Panara, G Renda, M G Sciulli, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1985
Drugs, prostaglandins, and renal functionC Patrono, G Ciabattoni, P Filabozzi, et al.
European Heart Journal|May 1, 1985
Low-dose aspirin in patients recovering from myocardial infarction. Evidence for a selective inhibition of thromboxane-related platelet functionR De Caterina, D Giannessi, W Bernini, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1994
Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthasesP Patrignani, M R Panara, A Greco, et al.
International Journal of Immunopathology and Pharmacology|June 13, 2013
Clinical pharmacology of cyclooxygenase inhibition and pharmacodynamic interaction with aspirin by floctafenine in Thai healthy subjectsR Maenthaisong, S Tacconelli, P Sritara, et al.
Anesthesia and Analgesia|January 1, 1985
Dose-related prolongation of the bleeding time by intravenous nitroglycerinP R Lichtenthal, E C Rossi, G Louis, et al.
Apoptosis : an International Journal on Programmed Cell Death|November 25, 2003
Cyclooxygenase-independent induction of p21WAF-1/cip1, apoptosis and differentiation by L-745,337, a selective PGH synthase-2 inhibitor, and salicylate in HT-29 cellsG Santini, M G Sciulli, R Marinacci, et al.
La Clinica Terapeutica|February 11, 2005
[Rationale of the use of COX-2 inhibitors in ENT pathologies]D Passali, M De Benedetto, C Giordano, et al.
The Journal of Clinical Investigation|January 1, 1982
Evidence for a direct stimulatory effect of prostacyclin on renin release in manC Patrono, F Pugliese, G Ciabattoni, et al.
British Journal of Pharmacology|July 1, 1996
Induction of prostaglandin endoperoxide synthase-2 in human monocytes associated with cyclo-oxygenase-dependent F2-isoprostane formationP Patrignani, G Santini, M R Panara, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 25, 1999
Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjectsM R Panara, G Renda, M G Sciulli, et al.
Pageof 8